前瞻性侧别标准下单侧放疗的口咽鳞癌对侧颈失败率低
中位随访32个月,3年局部区域控制率96%,对侧区域失败率0%,无远处转移生存率7%,无病生存率93%。结论认为采用前瞻性定义的侧别标准行单侧放疗,对侧颈失败率低,对侧器官耐受性得到尊重,患者报告轻至中度困扰。
要点
- 原发灶距中线>1 cm的口咽癌患者可考虑单侧放疗。
- 中位随访32个月,3年对侧区域失败率为0%。
- 3年局部区域控制率96%,无病生存率93%。
核心结论
- 采用前瞻性定义的侧别标准行单侧放疗,对侧颈失败率低。
主要发现
- 中位随访32个月,3年局部区域控制率为96%,对侧区域失败率为0%,无远处转移生存率为7%,无病生存率为93%。
- 患者特征:T1=11例,T2=22例,T3=4例;N0=3例,N1=9例,N2a=3例,N2b=21例,Nx=1例。
- 对侧器官耐受性得到尊重,患者报告整个治疗期间轻至中度困扰。
临床怎么用
- 对原发灶距中线>1 cm的口咽癌患者,可依据前瞻性侧别标准评估单侧放疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unilateral radiotherapy (RT) of oropharyngeal carcinomas is accepted for patients with lateralized primary and low-volume nodal disease. Utilizing prospectively defined criteria of laterality and staging positron emission tomography (PET)/CT, we studied outcomes in patients with advanced-stage oropharyngeal cancer undergoing unilateral RT. METHODS: Thirty-seven patients with oropharyngeal tumors >1 cm from midline regardless of node status underwent unilateral RT and were followed prospectively. Patient characteristics: T1 = 11; T2 = 22; T3 = 4; N0 = 3; N1 = 9; N2a = 3; N2b = 21; and Nx = 1. Dosimetry were determined and weekly National Comprehensive Cancer Network (NCCN) distress thermometer data were collected. RESULTS: At median follow-up of 32 months, 3-year locoregional control, contralateral regional failure, distant metastasis-free survival, and disease-free survival were 96%, 0%, 7%, and 93%, respectively. CONCLUSION: Low rates of contralateral neck failure are demonstrated utilizing prospectively defined criteria for unilateral RT. The tolerances of contralateral organs are respected and patients report low to moderate levels of distress throughout treatment.
引用
- Hu KS, Mourad WF, Gamez M, et al. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017. PMID: 28474380. doi:10.1002/hed.24806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。